Enoticumab (REGN421, SAR153192) is an IgG1kappa antibody that targets human Delta-like ligand 4 (Dll4), a crucial component of the Notch signaling pathway, modulating macropinocytosis-dependent long-chain fatty acid absorption. It demonstrated an 86% and 83%
CAS Number:
[1192578-27-0]
* VAT and and shipping costs not included. Errors and price changes excepted